LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult ...

LEO Pharma Unveils Most Extensive EADV Program To Date with 5 Late Breaking Abstracts and 23 Posters Sharing Clinical and ...

Jefferies analyst Michael Yee in a note to investors called rocatinlimab’s atopic dermatitis data “modest,” noting that the ...

Eczemas in the elderly often arise mysteriously and itch furiously. New-onset, otherwise unexplained eczema that cannot be attributed to atopic disease, irritant or allergic contact dermatitis ...

Childhood eczema tends to be localised to the face whilst eczema from the age of 2 onwards tends to present on the antecubital fossae and behind the knees. You can get adult onset and allergic contact ...

"A majority of adults in the U.S. have self-described sensitive skin and over 100 million people in the U.S. suffer from acne ...

If you feel like your face is always flushed, red, or rosy, one of these conditions could be the reason why. The post 11 ...

September is Eczema Awareness Month - and if you've any experience with the condition you'll know just how debilitating it can be.

ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of ...

Eli Lilly presents promising long-term data showing Ebglyss' efficacy in treating moderate-to-severe atopic dermatitis, with over 80% of patients maintaining clear skin for up to three years. FDA and ...

Galderma today announced that it will present new data from the ARCADIA and OLYMPIA clinical trial programs investigating ...